Cancer News and Research

Latest Cancer News and Research

Study: Full access to personal medical record increases cancer patient's trust in physicians

A new analysis has found that allowing full access to personal medical records increases satisfaction without increasing anxiety in newly diagnosed cancer patients. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that providing accurate information to patients through medical records can be a beneficial complement to verbal communication with their physicians.

23 May 2011

Automated microfluidic device can monitor hematopoietic stem cells

A Canadian research team has developed an automated microfluidic cell culture platform to monitor the growth, survival and responses of hundreds of hematopoietic stem cells at the single cell level.

23 May 2011

CT scan may help determine early death in individuals with diabetes

New findings out of Wake Forest Baptist Medical Center reveal that a common test may be useful in predicting early death in individuals with diabetes.

23 May 2011

Tumor necrosis factor can suppress inflammation, treat rheumatoid arthritis

A new study by rheumatologists at Hospital for Special Surgery in New York has shown that a powerful pro-inflammatory protein, tumor necrosis factor, can also suppress aspects of inflammation.

23 May 2011

Scientists invent Monolayer Stress Microscopy to measure physical forces during collective cellular migration

The physical forces that guide how cells migrate-how they manage to get from place to place in a coordinated fashion inside the living body- are poorly understood. Scientists at the Harvard School of Public Health and the Institute for Bioengineering of Catalonia have, for the first time, devised a way to measure these forces during collective cellular migration.

23 May 2011

Researchers identify new drug resistant protein in breast cancer

Researchers have identified a new protein involved in the development of drug resistance in breast cancer which could be a target for new treatments, they report today in the journal Nature Medicine.

23 May 2011

Global scientists rebuke coming decision on carcinogenicity of radiofrequency and microwaves

In collaboration with the International EMF Alliance (IEMFA), scientists from Europe, North America, Australia and Israel have sent an Open Letter to Dr. Christopher Wild, Director of the International Agency for Research on Cancer (IARC), calling for a postponement of the forthcoming meeting May 24-31, 2011 in Lyon, France, “Non-Ionizing Radiation, Part II: Radiofrequency Electromagnetic Field [includes mobile telephones],” at which determination of the carcinogenicity of cell phones and wireless technologies will be made.

22 May 2011

NIH allocated $400 million funding for pain research in 2010

An unprecedented level of federal funding for pain research, some $400 million, was allocated in 2010 by the National Institutes of Health (NIH) through provisions of the American Recovery and Investment Act and the Affordable Care Act to help accelerate advances in pain research, prevention and treatment.

21 May 2011

Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination

Eli Lilly and Company announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.

21 May 2011

Modified cells protect marrow and blood cells from harmful chemotherapy effects in brain tumor patients

Although chemotherapy is used to kill cancer cells, it can also have a strong toxic effect on normal cells such as bone marrow and blood cells, often limiting the ability to use and manage the chemotherapy treatment.

21 May 2011

FDA approves SUTENT for treatment of pancreatic NET

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SUTENT® (sunitinib malate) as the first anti-VEGF therapy to treat progressive, well-differentiated pancreatic neuroendocrine tumors (NET) in patients with unresectable locally advanced or metastatic disease. Pancreatic NET is a rare cancer reported in two to four people per million annually worldwide.

21 May 2011

Some cancer patients go without drugs because of high cost

New targeted pills can have dramatic effects on cancer, not only driving the disease into remission but also freeing patients from hours of uncomfortable and boring chemotherapy treatments. Up to 10 percent of patients, however, are not filling their prescriptions for the pills--and cost appears to be a factor, according to a new report.

21 May 2011

Breast cancer survivors, advocates stress importance of Every Woman Counts program

Responding to Governor Brown's announced revised budget, breast cancer survivors and advocates from across the state stressed the importance of early detection.

21 May 2011

Labour, delivery health professionals lack clear understanding of anesthesiologist's role: Study

Today, one in four or five women in Ontario will give birth through a cesarean or "C-section." A new study, led by researchers from St. Michael's Hospital and The Wilson Centre for Research in Education and the Department of Anesthesia, University of Toronto, has found that many labour and delivery health professionals lack a clear understanding of the anesthesiologist's role as a physician with specialized skills in the management of seriously unwell pregnant patients.

21 May 2011

Phase 3 open-label study of RELISTOR presented at American Pain Society meeting

Salix Pharmaceuticals, Ltd. today announced findings from two analyses of a Phase 3 open-label study of RELISTOR (methylnaltrexone bromide) presented at the 30th Annual Scientific Meeting of the American Pain Society. The meeting is being held in Austin, TX, on May 19-21, 2011.

21 May 2011

Stony Brook University CFB establishes Biotechnology Commercialization Fund

The Center for Biotechnology (CFB) at Stony Brook University has established the Biotechnology Commercialization Fund to accelerate the development of promising biomedical technologies emerging from Stony Brook University.

21 May 2011

Researchers uncover new details of unusual biological mechanism in brains of diverse species

Researchers at the University of California, San Diego School of Medicine have uncovered new details of an unusual biological mechanism in the brains of diverse species that not only helps regulate how their brains develop, but also how they function later in life. The discovery could lead to new biomarkers for specific neurological diseases in humans and, possibly, the development of drugs to cure them.

21 May 2011

Bristol-Myers Squibb to present abstracts on oncology compounds at ASCO 2011 Annual Meeting

Bristol-Myers Squibb Company, a leading global BioPharma company in oncology, today announced that more than 95 scientific abstracts on its approved and investigational oncology compounds will be featured at the 47th Annual Meeting of the American Society of Clinical Oncology in Chicago from June 3-7.

21 May 2011

Researchers develop cheap, reliable diagnostic test for HLRCC

Researchers at the University of Oxford have developed a cheap and reliable diagnostic test for a rare form of cancer. The test involves screening tumour samples for a particular molecular fingerprint unique to this type of cancer.

21 May 2011

Healthier diet associated with less weight gain in African American women: Study

Investigators from the Slone Epidemiology Center at Boston University have reported that African American women who consumed a diet high in vegetables and fruit gained less weight over a 14-year period than those who consumed a diet high in red meat and fried foods.

21 May 2011

Cancer News and Research

Latest Cancer News and Research

Study: Full access to personal medical record increases cancer patient's trust in physicians

Automated microfluidic device can monitor hematopoietic stem cells

CT scan may help determine early death in individuals with diabetes

Tumor necrosis factor can suppress inflammation, treat rheumatoid arthritis

Scientists invent Monolayer Stress Microscopy to measure physical forces during collective cellular migration

Researchers identify new drug resistant protein in breast cancer

Global scientists rebuke coming decision on carcinogenicity of radiofrequency and microwaves

NIH allocated $400 million funding for pain research in 2010

Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination

Modified cells protect marrow and blood cells from harmful chemotherapy effects in brain tumor patients

FDA approves SUTENT for treatment of pancreatic NET

Some cancer patients go without drugs because of high cost

Breast cancer survivors, advocates stress importance of Every Woman Counts program

Labour, delivery health professionals lack clear understanding of anesthesiologist's role: Study

Phase 3 open-label study of RELISTOR presented at American Pain Society meeting

Stony Brook University CFB establishes Biotechnology Commercialization Fund

Researchers uncover new details of unusual biological mechanism in brains of diverse species

Bristol-Myers Squibb to present abstracts on oncology compounds at ASCO 2011 Annual Meeting

Researchers develop cheap, reliable diagnostic test for HLRCC

Healthier diet associated with less weight gain in African American women: Study

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in